Antihypertensive Treatment According to Age, Plasma Renin and Race

Overview

Journal Drugs

Specialty Pharmacology

Date 1988 May 1

PMID 2899494

Citations 13

Authors

F R Buhler

Affiliations

Soon will be listed here.

Abstract

Recent large scale antihypertensive treatment trials emphasise the importance of blood pressure control in reducing both cerebrovascular accidents and myocardial infarction. Obviously therefore, the drug that best normalises blood pressure while producing the fewest adverse effects should be sought. On the basis of studies demonstrating cellular membrane and calcium homeostatic derangements and an age-dependent transition of overall cardiovascular regulation and peripheral vasoconstrictor forces during the course of essential hypertension, this review proposes an alternative treatment. Under this treatment scheme angiotensin converting enzyme inhibitors or beta-blockers should be used in younger patients and in those with high plasma renin activity, while calcium antagonists are used in place of diuretics in older low-renin or Black patients. Age-oriented 2-way drug selection enables a normalisation of blood pressure without untoward effects in about 80% of patients with essential hypertension and helps to optimise drug combinations in those patients who are difficult to treat.

Citing Articles

Are there benefits of antihypertensive therapy beyond blood pressure lowering?.

Izzo Jr J Curr Hypertens Rep. 2010; 12(6):440-7.

PMID: 20978874 DOI: 10.1007/s11906-010-0160-0.

Obesity as a determinant for response to antihypertensive treatment.

Schmieder R, Gatzka C, Schachinger H, Schobel H, Ruddel H BMJ. 1993; 307(6903):537-40.

PMID: 8400973 PMC: 1678609. DOI: 10.1136/bmj.307.6903.537.

Choosing the right ACE inhibitor. A guide to selection.

Leonetti G, Cuspidi C Drugs. 1995; 49(4):516-35.

PMID: 7789286 DOI: 10.2165/00003495-199549040-00003.

Guidelines for treating hypertension in the elderly.

Emeriau J Drugs. 1989; 38(4):612-20.

PMID: 2684595 DOI: 10.2165/00003495-198938040-00007.

Antihypertensive effects of nitrendipine and cilazapril alone, and in combination in hypertensive patients with chronic renal failure.

Kloke H, Huysmans F, Wetzels J, Sluiter H, Kleinbloesem C, Koene R Br J Clin Pharmacol. 1989; 27 Suppl 2:289S-296S.

PMID: 2527541 PMC: 1379760. DOI: 10.1111/j.1365-2125.1989.tb03494.x.

References

Brunner H, SEALEY J, LARAGH J . Renin subgroups in essential hypertension. Further analysis of their pathophysiological and epidemiological characteristics. Circ Res. 1973; 32:Suppl 1:99-105. View

Buhler F, Hulthen U, Kiowski W, Muller F, Bolli P . The place of the calcium antagonist verapamil in antihypertensive therapy. J Cardiovasc Pharmacol. 1982; 4 Suppl 3:S350-7. View

Sweet C, Kadowitz P, BRODY M . Arterial hypertension elicited by prolonged intra-vertebral infusion of angiotensin II in conscious dog. Am J Physiol. 1971; 221(6):1640-4. DOI: 10.1152/ajplegacy.1971.221.6.1640. View

Erne P, Bolli P, Burgisser E, Buhler F . Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy. N Engl J Med. 1984; 310(17):1084-8. DOI: 10.1056/NEJM198404263101705. View

. Effects of treatment on morbidity in hypertension. 3. Influence of age, diastolic pressure, and prior cardiovascular disease; further analysis of side effects. Circulation. 1972; 45(5):991-1004. DOI: 10.1161/01.cir.45.5.991. View

Carvalho A, Colman R, Lees R . Platelet function in hyperlipoproteinemia. N Engl J Med. 1974; 290(8):434-8. DOI: 10.1056/NEJM197402212900805. View

Bolli P, Erne P, Ji B, BLOCK L, Kiowski W, Buhler F . Adrenaline induces vasoconstriction through post-junctional alpha 2 adrenoceptors and this response is enhanced in patients with essential hypertension. J Hypertens Suppl. 1984; 2(3):S115-8. View

. Cardiovascular risk and risk factors in a randomized trial of treatment based on the beta-blocker oxprenolol: the International Prospective Primary Prevention Study in Hypertension (IPPPSH). The IPPPSH Collaborative Group. J Hypertens. 1985; 3(4):379-92. DOI: 10.1097/00004872-198508000-00011. View

Gribbin B, Pickering T, Sleight P, Peto R . Effect of age and high blood pressure on baroreflex sensitivity in man. Circ Res. 1971; 29(4):424-31. DOI: 10.1161/01.res.29.4.424. View

10.

Oliver M, Kurien V, Greenwood T . Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction. Lancet. 1968; 1(7545):710-4. DOI: 10.1016/s0140-6736(68)92163-6. View

11.

Brouwer R, Follath F, Buhler F . Review of the cardiovascular adversity of the calcium antagonist beta-blocker combination: implications for antihypertensive therapy. J Cardiovasc Pharmacol. 1985; 7 Suppl 4:S38-44. DOI: 10.1097/00005344-198507004-00008. View

12.

Moser M, Lunn J . Responses to captopril and hydrochlorothiazide in black patients with hypertension. Clin Pharmacol Ther. 1982; 32(3):307-12. DOI: 10.1038/clpt.1982.165. View

13.

Kiowski W, Julius S . Renin response to stimulation of cardiopulmonary mechanoreceptors in man. J Clin Invest. 1978; 62(3):656-63. PMC: 371812. DOI: 10.1172/JCI109173. View

14.

Croog S, Levine S, Testa M, Brown B, Bulpitt C, Jenkins C . The effects of antihypertensive therapy on the quality of life. N Engl J Med. 1986; 314(26):1657-64. DOI: 10.1056/NEJM198606263142602. View

15.

Muller F, SEALEY J, Case D, Atlas S, Pickering T, Pecker M . The captopril test for identifying renovascular disease in hypertensive patients. Am J Med. 1986; 80(4):633-44. DOI: 10.1016/0002-9343(86)90819-3. View

16.

. 1986 guidelines for the treatment of mild hypertension: memorandum from a WHO/ISH meeting. J Hypertens. 1986; 4(3):383-6. DOI: 10.1097/00004872-198606000-00021. View

17.

Buhler F, Kiowski W, van Brummelen P, Amann F, Bertel O, Landmann R . Plasma catecholamines and cardiac, renal and peripheral vascular adrenoceptor-mediated responses in different age groups of normal and hypertensive subjects. Clin Exp Hypertens (1978). 1980; 2(3-4):409-26. DOI: 10.3109/10641968009037122. View

18.

Jie K, van Brummelen P, Vermey P, Timmermans P, van Zwieten P . Alpha 1-and alpha 2-adrenoceptor mediated vasoconstriction in the forearm of normotensive and hypertensive subjects. J Cardiovasc Pharmacol. 1986; 8(1):190-6. DOI: 10.1097/00005344-198601000-00028. View

19.

Muller F, Ha H, Hotz H, Schmidlin O, Follath F, Buhler F . Once a day verapamil in essential hypertension. Br J Clin Pharmacol. 1986; 21 Suppl 2:143S-147S. PMC: 1400729. DOI: 10.1111/j.1365-2125.1986.tb02863.x. View

20.

Resink T, Dimitrov D, Zschauer A, Erne P, Tkachuk V, Buhler F . Platelet calcium-linked abnormalities in essential hypertension. Ann N Y Acad Sci. 1986; 488:252-65. DOI: 10.1111/j.1749-6632.1986.tb46563.x. View